CIK 0001175680
- Non-accelerated filer
- Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753056237
- Phone
- +1 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-20 | SIMES STEPHEN M Director | Grant or award · Non-qualified stock option (right to buy) | +574,385 | 574,385 | ||
| 2024-10-28 | SIMES STEPHEN M Director | Grant or award · Non-qualified stock option (right to buy) | +800,000 | 800,000 | ||
| 2024-01-03 | SIMES STEPHEN M Director | Grant or award · Non-qualified stock option (right to buy) | +800,000 | 800,000 | ||
| 2022-10-24 | SIMES STEPHEN M Director | Grant or award · Non-qualified stock option (right to buy) | +178,012 | 178,012 |
Page 1 of 1 · 4 trades